4.7 Article

Altered intestinal microbiome and metabolome correspond to the clinical outcome of sepsis

Journal

CRITICAL CARE
Volume 27, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13054-023-04412-x

Keywords

Sepsis; Gut microbiota; Gut metabolites; Enterococcus; Bacteroides; Tryptophan metabolism

Ask authors/readers for more resources

This study used microbiome and untargeted metabolomics to analyze stool samples from sepsis patients and identified microbial and metabolic features that may play important roles in disease outcome. Animal model analysis further validated the findings. These findings could help predict the clinical outcome of sepsis patients and provide a basis for exploring new therapies.
BackgroundThe gut microbiome plays a pivotal role in the progression of sepsis. However, the specific mechanism of gut microbiota and its metabolites involved in the process of sepsis remains elusive, which limits its translational application.MethodIn this study, we used a combination of the microbiome and untargeted metabolomics to analyze stool samples from patients with sepsis enrolled at admission, then microbiota, metabolites, and potential signaling pathways that might play important roles in disease outcome were screened out. Finally, the above results were validated by the microbiome and transcriptomics analysis in an animal model of sepsis.ResultsPatients with sepsis showed destruction of symbiotic flora and elevated abundance of Enterococcus, which were validated in animal experiments. Additionally, patients with a high burden of Bacteroides, especially B. vulgatus, had higher Acute Physiology and Chronic Health Evaluation II scores and longer stays in the intensive care unit. The intestinal transcriptome in CLP rats illustrated that Enterococcus and Bacteroides had divergent profiles of correlation with differentially expressed genes, indicating distinctly different roles for these bacteria in sepsis. Furthermore, patients with sepsis exhibited disturbances in gut amino acid metabolism compared with healthy controls; namely, tryptophan metabolism was tightly related to an altered microbiota and the severity of sepsis.ConclusionAlterations in microbial and metabolic features in the gut corresponded with the progression of sepsis. Our findings may help to predict the clinical outcome of patients in the early stage of sepsis and provide a translational basis for exploring new therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available